Unknown PHASE2 INTERVENTIONAL NCT01047969

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Non-Operative Treatment for Rectal Cancer Following Complete Response to Neo-Adjuvant Therapy

Sponsor: Royal Marsden NHS Foundation Trust

Interventions Adjuvant Chemotherapy Surgery

Updated 6 times since 2017 Last updated: Jun 12, 2019 Started: Jun 6, 2006 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Rectal Adenocarcinoma and is currently ongoing. Royal Marsden NHS Foundation Trust leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jul 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Active Not Recruiting PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Marsden NHS Foundation Trust

Data source: Royal Marsden NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom